@thepatientinvestorr
YouTube
Avg. Quality
69
Success Rate
24.32
Analysis
222
Correct
54
Fail
118
Pending
44
Ineffective
0
Total Quality
Score
If You Had Traded on This Analysis…
Pending
PYPL
Long Entry
40.4100
2026-02-07
00:26 UTC
Target
68.0000
Fail
25.0000
Risk/Reward
1 : 2
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
Live PnL
—
P/L: —
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
The analysis covers two stocks, PYPL and NVO. PYPL's financials are discussed, showing a decline in active accounts and revenue growth, but also a strong free cash flow and a low P/E ratio, suggesting potential undervaluation. NVO shows mixed performance with declines in market share in diabetes care and obesity care, but strong patent protection and a solid forward P/E ratio. The speaker expresses a bullish outlook on both stocks based on their fundamentals and potential for market share gains, despite recent price drops.
